You are here: Industry Insights > Cardiovascular disease

News List

Verve Therapeutics to develop cardiovascular disease treatments pharmaceutical-technology
May 09, 2019
Cardiovascular company Verve Therapeutics has been founded following a series A financing round.
Praluent (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease firstwordpharma
March 18, 2019
The European Commission (EC) has approved a new indication for Praluent®(alirocumab), to reduce cardiovascular (CV) risk in adults with established atherosclerotic CV disease (ASCVD) by lowering low-density lipoprotein cholesterol (LDL-C) levels as an adj
NICE updates high blood pressure guidelines pharmatimes
March 12, 2019
The National Institute for Health and Care Excellence (NICE) has published a draft updated guideline on the diagnosis and treatment of high blood pressure (hypertension).
NICE updates high blood pressure guidelines pharmatimes
March 12, 2019
The National Institute for Health and Care Excellence (NICE) has published a draft updated guideline on the diagnosis and treatment of high blood pressure (hypertension).
Morning Exercise Linked to BP Reduction in Sedentary Seniors drugs
February 21, 2019
In sedentary overweight/obese older adults, morning exercise reduces systolic blood pressure, with additional benefit seen by combining exercise with regular breaks in sitting....
Cipla taps Wellthy for digital therapeutics expertise pharmaphorum
February 20, 2019
Indian pharma company Cipla has made another play in the digital medicine category by taking a near-12% stake in start-up Wellthy Therapeutics.
Novo bags €430M Staten buyout option to boost cardiovascular disease pipeline fiercebiotech
December 26, 2018
Novo Nordisk has landed an option to buy Staten Biotechnology in a €430 million ($485 million) deal. The agreement gives Novo the chance to add an anti-apoC3 antibody treatment for abnormal lipid levels to its pipeline....
Residential Greenness Linked to Cardiovascular Disease Risk drugs
December 20, 2018
The density of greenness near residences is associated with lower urinary levels of epinephrine and F2-isoprostane, according to a study published in the Dec. 18 issue of the Journal of the American Heart Association....
Statins overprescribed for primary prevention en-cphi.cn
December 07, 2018
Statins overprescribed for primary prevention
Women with pregnancy losses are at risk of cardiovascular disease pharmaceutical-technology
December 03, 2018
Research from the UK’s University of Cambridge and the University of North Carolina in the US has revealed women have an increased risk of cardiovascular disease from pregnancy losses and having five or more children......

Previous page 1 2 3 Next page